NYC Hip Fracture Patients with COVID-19: Higher Death Rates
OrthoSpineNews reports on the findings of an HSS study co-authored by Drake LeBrun, MD, MPH, published in The Journal of Orthopaedic Trauma, which found geriatric hip fracture patients with concomitant COVID-19 had higher rates of inpatient mortality compared to those without COVID-19.
Dr. LeBrun and researchers evaluated data from HSS and NewYork-Presbyterian Queens, involving 59 consecutive hip fracture patients (average age 85 years, range: 65–100 years) treated over a 5-week period (March 20, 2020, to April 24, 2020), to better understand how hip fracture patients treated during the height of the COVID-19 pandemic in NYC have fared. Of the 59 patients, 10 (15 percent) tested positive for COVID-19 or were presumed positive, 40 (68 percent) tested negative, and 9 (15 percent) were not tested in the primary hospitalization.
Dr. LeBrun noted, “We found that geriatric hip fracture patients with concomitant COVID-19 had higher rates of inpatient mortality compared to those without COVID-19. What was partly surprising about this finding is that although 5 of 9 patients with concomitant COVID-19 expired, 4 of 9 had few, if any, symptoms related to COVID-19 and had an otherwise unremarkable hospital course.” He added, “Our study found that patients who sustained a hip fracture and had concomitant COVID-19 infection were more likely to expire during their hospitalization. Relative to patients who did not have COVID-19, those with concomitant COVID-19 infection were also more likely to be have low oxygen levels postoperatively, develop pneumonia, and require ICU admission during their hospitalization.”
Read the full article at OrthoSpineNews.com.
Connect With Us
Resources to Feel Better From Home
Subscribe to our eNewsletters